Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.880
-0.080 (-4.08%)
Sep 13, 2024, 11:54 AM EDT - Market open
Actinium Pharmaceuticals Stock Forecast
ATNM's stock price has decreased by -71.92% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ATNM stock have an average target of 13.77, with a low estimate of 4.00 and a high estimate of 25. The average target predicts an increase of 632.45% from the current stock price of 1.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 6, 2024.
Analyst Ratings
The average analyst rating for ATNM stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $4 | Strong Buy | Maintains | $50 → $4 | +112.77% | Aug 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $5 | Strong Buy | Maintains | $30 → $5 | +165.96% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +2,559.57% | Jul 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +2,559.57% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +2,559.57% | May 21, 2024 |
Financial Forecast
Revenue This Year
n/a
from 81.00K
Revenue Next Year
37.59M
EPS This Year
-1.34
from -1.83
EPS Next Year
-0.80
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 40.6M | 93.2M | ||
| Avg | n/a | 37.6M | 90.6M | ||
| Low | n/a | 34.3M | 87.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 148.1% | ||
| Avg | - | - | 141.0% | ||
| Low | - | - | 131.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.20 | 0.08 | -1.00 | ||
| Avg | -1.34 | -0.80 | -1.19 | ||
| Low | -1.53 | -1.42 | -1.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.